Skip to main content
Clinical Trials/CTRI/2018/02/011832
CTRI/2018/02/011832
Recruiting
未知

Comparison of post cataract surgery visual outcomes in patients bilaterally implanted with Eyecryl ACTV Diffractive Multifocal IOL & AcrySof® IQ ReSTOR® Multifocal IO

Biotech Vision Care Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Biotech Vision Care Pvt Ltd
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Biotech Vision Care Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • Patients who has been implanted bilaterally with any one of the Multifocal IOL: Eyecryl ACTV Diffractive Multifocal IOL OR AcrySof® IQ ReSTOR® multifocal IOL will be included in the study.
  • Age 18 and older
  • Regular corneal topography and corneal astigmatism
  • Preoperative \& postoperative corneal astigmatism of \<\= 0\.75D
  • Clear intraocular media
  • Availability, willingness and sufficient cognitive awareness to comply with examination procedures
  • Written informed consent for participation in the study and data protection

Exclusion Criteria

  • Patients with best corrected vision less than 6/9 and or N/6
  • Pupil Size: \> 5 mm scotopic size
  • Previous ocular surgery.
  • Any active ocular disease (Diabetic retinopathy, macular degeneration, glaucoma with field defects and irregular corneal astigmatism)
  • Any ocular pathology (corneal, retinal)
  • Subject who are professional Pilots/truck/Car Drivers

Outcomes

Primary Outcomes

Not specified

Similar Trials